AIM: to know the effectiveness of antiretroviral treatment (ART) among methadone clients and patients who started ART outside the methadone program during the same period. METHODS: uptake of HIV testing and treatment were evaluated in a cohort of IDUs starting MMT. Effectiveness of anti-retroviral treatment (ART) was compared with matched 175 HIV-patients with a history of IDU outside MMT. RESULTS: overall, 223 patients were enrolled in MMT between May 2006 and January 2009, of whom 44% were tested for HIV, with an HIV prevalence of 73%. Screening of MMT clients was responsible for diagnosing HIV and starting ART in 31.9%, respectively 45.7%. Two year retention (100% vs 97.1%; p=0.23) and survival (93.9% vs 92.3%; p=0.76) during ART were not significantly different for 35 patients who combined ART with methadone, and the control group (n=175). Virological failure was found in one patient (3.7%) in MMT compared to 10.5% of the control group. CONCLUSION: providing HIV testing and treatment is a feasible and effective way to increase detection and treatment of HIV among clients enrolled in MMT. HIV- treatment integrated with methadone maintenance can be very effective. These results support wider application of integrated HIV care and opioid substitution.
AIM: to know the effectiveness of antiretroviral treatment (ART) among methadone clients and patients who started ART outside the methadone program during the same period. METHODS: uptake of HIV testing and treatment were evaluated in a cohort of IDUs starting MMT. Effectiveness of anti-retroviral treatment (ART) was compared with matched 175 HIV-patients with a history of IDU outside MMT. RESULTS: overall, 223 patients were enrolled in MMT between May 2006 and January 2009, of whom 44% were tested for HIV, with an HIV prevalence of 73%. Screening of MMT clients was responsible for diagnosing HIV and starting ART in 31.9%, respectively 45.7%. Two year retention (100% vs 97.1%; p=0.23) and survival (93.9% vs 92.3%; p=0.76) during ART were not significantly different for 35 patients who combined ART with methadone, and the control group (n=175). Virological failure was found in one patient (3.7%) in MMT compared to 10.5% of the control group. CONCLUSION: providing HIV testing and treatment is a feasible and effective way to increase detection and treatment of HIV among clients enrolled in MMT. HIV- treatment integrated with methadone maintenance can be very effective. These results support wider application of integrated HIV care and opioid substitution.
Authors: Benjamin J Oldfield; Nicolas Muñoz; Mark P McGovern; Melissa Funaro; Merceditas Villanueva; Jeanette M Tetrault; E Jennifer Edelman Journal: AIDS Date: 2019-04-01 Impact factor: 4.177
Authors: Yan Zhao; Cynthia X Shi; Jennifer M McGoogan; Keming Rou; Fujie Zhang; Zunyou Wu Journal: Bull World Health Organ Date: 2013-02-01 Impact factor: 9.408
Authors: Shelly Iskandar; Cor Aj de Jong; Teddy Hidayat; Ike Mp Siregar; Tri H Achmad; Reinout van Crevel; Andre van der Ven Journal: J Multidiscip Healthc Date: 2012-12-14
Authors: Victoria Haldane; Francisco Cervero-Liceras; Fiona Lh Chuah; Suan Ee Ong; Georgina Murphy; Louise Sigfrid; Nicola Watt; Dina Balabanova; Sue Hogarth; Will Maimaris; Kent Buse; Peter Piot; Martin McKee; Pablo Perel; Helena Legido-Quigley Journal: J Int AIDS Soc Date: 2017-05-30 Impact factor: 5.396
Authors: Nicola Watt; Louise Sigfrid; Helena Legido-Quigley; Sue Hogarth; Will Maimaris; Laura Otero-García; Pablo Perel; Kent Buse; Martin McKee; Peter Piot; Dina Balabanova Journal: Health Policy Plan Date: 2017-11-01 Impact factor: 3.344
Authors: Bach Xuan Tran; Long Hoang Nguyen; Lan Phuong Nguyen; Cuong Tat Nguyen; Huong Thi Thu Phan; Carl A Latkin Journal: PLoS One Date: 2016-04-05 Impact factor: 3.240